Ohio State University James Cancer Hospital and Solove Research Institute

Columbus, Ohio 43210

We've found

1 trials

at this facility

Study of the Safety, Tolerability and Efficacy of KPT-8602 in Patients With Relapsed/Refractory Cancer Indications

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Columbus, OH

Use our guide to learn which trials are right for you!